NASDAQ:ATOS
Atossa Therapeutics Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.atossatherapeutics.comipo date
Nov 08, 2012
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to ...Show More
Earnings
Earnings Release in 16 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus